International Journal of Epidemiology 2001;30:616-621
© International Epidemiological Association 2001
Other Original Papers |
Impact of smoking habit on medical care use and its costs: a prospective observation of National Health Insurance beneficiaries in Japan
Department of Public Health, Tohoku University School of Medicine, Sendai, Japan.
Yoko Izumi, Department of Public Health, Tohoku University School of Medicine, 21 Seiryo-machi, Aoba-ku, Sendai, 980-8575 Japan. E-mail: BZE16213{at}nifty.ne.jp
Abstract
Background To quantify excess medical use associated with smoking, a large prospective cohort study is needed. The authors examined the impact of smoking on medical care use in a large population-based cohort with an accurate data collecting system in Japan.
Method The data were derived from a 30-month prospective cohort study of 43 408 National Health Insurance beneficiaries aged 4079 years living in a rural Japanese community. The smoking habit of beneficiaries was assessed in a baseline survey at the end of 1994. Medical care use and its costs were monitored by linkage with the National Health Insurance claim history files since January 1995.
Results Male smokers incurred 11% more medical costs (after adjustment for age, physical functioning status, alcohol consumption, body mass index and average time spent walking) than never smokers but for female smokers and never smokers the costs were almost the same. This difference was mainly attributable to increased use of inpatient medical care among smokers, especially in males, where per month cost of inpatient care was 33% higher in smokers. Age-group specific analysis in men showed that excess mortality and excess medical cost ratio for smokers peaked in those aged 6069 years.
Conclusions Smokers consume excess medical care. Among the population aged 45 years and over, about 4% of total medical costs were attributable to smoking. To pursue both better health and lower medical costs for the nation, a comprehensive programme to reduce tobacco use is needed.
KEY MESSAGES
- The impact of smoking on medical care use was examined in a 30-month prospective population-based cohort study in Japan (N = 43 408).
- Male smokers incurred 11% more medical costs than never smokers but for female smokers and never smokers the costs were almost the same.
- This difference was mainly attributable to the increased use of inpatient medical care among smokers, especially in males, where per month cost of inpatient care was 33% higher in smokers.
Keywords Cohort study, smoking, medical costs
Accepted 10 October 2000
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C.-W. Chung, J.-D. Wang, C.-F. Yu, and M.-C. Yang Lifetime medical expenditure and life expectancy lost attributable to smoking through major smoking related diseases in Taiwan Tob. Control, December 1, 2007; 16(6): 394 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M McGhee, L M Ho, H M Lapsley, J Chau, W L Cheung, S Y Ho, M Pow, T H Lam, and A J Hedley Cost of tobacco-related diseases, including passive smoking, in Hong Kong. Tob. Control, April 1, 2006; 15(2): 125 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Nakagawa, M. L. Franchini, P. Driusso, L. R. de Oliveira, P. H. N. Saldiva, and G. Lorenzi-Filho Mucociliary Clearance Is Impaired in Acutely Ill Patients Chest, October 1, 2005; 128(4): 2772 - 2777. [Abstract] [Full Text] [PDF] |
||||
![]() |
M C Yang, C Y Fann, C P Wen, and T Y Cheng Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan Tob. Control, June 1, 2005; 14(suppl_1): i62 - i70. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tsuji, K. Takahashi, Y. Nishino, T. Ohkubo, S. Kuriyama, Y. Watanabe, Y. Anzai, Y. Tsubono, and S. Hisamichi Impact of walking upon medical care expenditure in Japan: the Ohsaki Cohort Study Int. J. Epidemiol., October 1, 2003; 32(5): 809 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P Rice Commentary: Impact of smoking habit on medical care use and its costs Int. J. Epidemiol., June 1, 2001; 30(3): 622 - 623. [Full Text] [PDF] |
||||


